Almudena Rodriguez-Gil
Santiago De Compostela, GA 15782, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
BioFRAM PGx, an Implementation Proposal for Pharmacogenetics in the Spanish National Health System.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: July 02, 2026
Advancing Personalized Medicine in Psychiatry: A Descriptive Pilot Study Integrating Pharmacogenetics and Pharmacokinetics in Long-Acting Antipsychotic Treatment.
Journal: Pharmaceutics
Published: July 02, 2026
A Lack of Complete Linkage Disequilibrium Between c.1236G>A and c.1129-5923C>G HapB3 Variants of DPYD: A Call to Revise European Pharmacogenetic Guidelines.
Journal: International journal of molecular sciences
Published: July 05, 2025
Exploring the sensory profile and pharmacogenetic biomarkers in child and youth ADHD patients undergoing methylphenidate (MPH) treatment: a systematic review conducted in European studies.
Journal: Journal of psychiatric research
Published: June 26, 2025
The Relevance of Pharmacokinetic Biomarkers in Response to Methadone Treatment: A Systematic Review.
The Relevance of Pharmacokinetic Biomarkers in Response to Methadone Treatment: A Systematic Review.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: March 31, 2025
Differences in DPYD Population Frequencies Observed in Galicians Compared to Europeans and Spanish from PhotoDPYD Study.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: February 27, 2025
Pharmacogenomic Study of SARS-CoV-2 Treatments: Identifying Polymorphisms Associated with Treatment Response in COVID-19 Patients.
Journal: Biomedicines
Published: December 13, 2024
Balance of care activity after EMA recommendation for DPYD gene testing in Galicia.
Journal: Frontiers in pharmacology
Published: November 06, 2024
Status of the implementation of pharmacogenetics in clinical practice in Spain: from regional to national initiatives.
Journal: Drug metabolism and personalized therapy
Published: June 06, 2024
Influence of Genetic Polymorphisms on the Short-Term Response to Ranibizumab in Patients With Neovascular Age-Related Macular Degeneration.
Journal: Investigative ophthalmology & visual science
Published: October 20, 2023
Towards precision medicine of long-acting aripiprazole through population pharmacokinetic modelling.
Towards precision medicine of long-acting aripiprazole through population pharmacokinetic modelling.
Journal: Psychiatry research
Published: October 11, 2023
Deletion of the CYP2D6 gene as a likely explanation for the serious side effects of the antipsychotic drug pimozide: a case report.
Journal: Frontiers in pharmacology
Published: June 09, 2023
Showing 1-12 of 12
Last Updated: 09/26/2026